Global Coronary Artery Bypass Grafts Market Size By Type (Off-pump CABG, On-pump CABG), By Application (Hospitals, Ambulatory surgical centers (ASCs)), By Region, And Segment Forecasts, 2023 to 2032

lobal Coronary Artery Bypass Grafts Market Report Description

The Global Coronary Artery Bypass Grafts (CABG) Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 3.7 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The increasing prevalence of coronary artery disease (CAD), aging population, and advancements in surgical techniques are major factors driving market growth. The market is also influenced by the rising number of lifestyle-related disorders such as diabetes and hypertension, which are significant risk factors for CAD. Additionally, the increasing preference for off-pump and minimally invasive CABG procedures is contributing to the expansion of the market.

Drivers:

1. Rising Incidence of Coronary Artery Disease:

The global burden of cardiovascular diseases continues to rise, with coronary artery disease being one of the leading causes of death worldwide. This has significantly increased the demand for effective surgical interventions such as CABG.

2. Technological Advancements in Graft Materials and Surgical Procedures:

Innovations in synthetic and biological graft materials, coupled with developments in robotic and minimally invasive surgical techniques, are improving patient outcomes and enhancing procedural safety.

3. Growing Geriatric Population:

The aging population is more susceptible to heart-related conditions, thereby fueling the need for coronary artery bypass surgeries.

Restraints:

1. High Cost of CABG Procedures:

The overall expense associated with CABG, including hospitalization, surgical equipment, and post-operative care, can be prohibitive, especially in low-income and underinsured populations.

2. Availability of Alternative Treatments:

The increasing adoption of percutaneous coronary interventions (PCIs) such as angioplasty and stenting, which are less invasive than CABG, poses a significant challenge to market growth.

Opportunity:

1. Growth in Emerging Economies:

Countries such as India, China, and Brazil present lucrative opportunities due to improving healthcare infrastructure, rising healthcare spending, and growing awareness of cardiovascular health.

2. Increasing Use of Arterial Grafts:

The shift from venous to arterial grafts, especially the use of internal mammary arteries, is resulting in better long-term patency rates, driving the adoption of CABG procedures.

Market by System Type Insights:

The Off-pump CABG segment accounted for the largest market share in 2023. Off-pump techniques are increasingly preferred due to reduced complications, shorter hospital stays, and quicker recovery times compared to on-pump surgeries. The Minimally Invasive CABG segment is expected to grow at the fastest rate, propelled by advancements in surgical robotics and patient preference for less invasive treatment options.

Market by End-use Insights:

In 2023, hospitals emerged as the dominant end-user segment, contributing over 60% of the total market share. Hospitals offer comprehensive cardiac care, advanced surgical facilities, and highly skilled medical personnel. Cardiac centers are expected to witness substantial growth as specialized facilities gain traction in both developed and developing regions for performing complex procedures like CABG.

Market by Regional Insights:

North America led the market in 2023, driven by high healthcare spending, established reimbursement frameworks, and a growing elderly population. Asia-Pacific is anticipated to witness the highest CAGR during the forecast period, supported by improving healthcare access, increased prevalence of CAD, and government initiatives promoting cardiac health awareness.

Competitive Scenario:

Key players in the market include Medtronic plc, Terumo Corporation, Getinge AB, Boston Scientific Corporation, LivaNova PLC, Cardiva Medical, Inc., MAQUET Holding B.V. & Co. KG, Edwards Lifesciences Corporation, and CryoLife, Inc. These companies are focusing on strategic mergers, new product development, and geographic expansion to enhance their market position.

Key Market Developments:

In 2023, Terumo Corporation launched a new generation of synthetic vascular grafts designed for improved biocompatibility and durability.

Medtronic plc announced an expansion of its CABG product portfolio with advanced off-pump surgery instruments in 2024.

Getinge AB formed a strategic alliance in 2025 to introduce robotic-assisted CABG systems across Europe and Asia.

Scope of Work – Global Coronary Artery Bypass Grafts Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 3.7 billion

CAGR (2023–2031) 7.1%

Market Segments By System Type, End-use, Region

Growth Drivers Rising prevalence of CAD, aging population, advancements in graft materials

Opportunities Emerging markets, adoption of arterial grafts

FAQs

1) What is the current market size of the Global Coronary Artery Bypass Grafts Market?

The market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Coronary Artery Bypass Grafts Market?

The major driver is the rising prevalence of coronary artery disease (CAD) globally.

3) Which is the largest region during the forecast period in the Global Coronary Artery Bypass Grafts Market?

North America is the largest region in the market.

4) Which segment accounted for the largest market share in the Global Coronary Artery Bypass Grafts Market?

The Off-pump CABG system type segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Coronary Artery